A Study of the Association Between Tobacco Smoking and Bipolar Affective Disorder

NCT ID: NCT00741299

Last Updated: 2012-07-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2007-08-31

Study Completion Date

2009-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to examine whether tobacco smoking is associated with bipolar affective disorder (severity of depressive and manic symptoms, presence of psychotic symptoms, history of a suicide attempts and other clinical features.)

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

An association exists between smoking and schizophrenia, independent of other factors and related to psychotic symptomatology. Only a few small descriptive studies have examined the prevalence and correlates of tobacco use among bipolar patients with conflicting results. Patients who smoke score higher on rating scales for psychotic symptoms than their non-smoking peers. While the association of smoking with psychotic symptomatology in schizophrenia is established, such association according to bipolar affective disorder has been reported in a few studies and remains unclear. Also a few studies reported about association of smoking with depressive and manic symptoms, and with suicidal behavior in bipolar patients. Thus further investigation of these issues is warranted.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Bipolar Disorder

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

bipolar affective disorder, Smoking

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Study Time Perspective

RETROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 18-65 male or female
* DSM -IV criteria for bipolar I affective disorder
* Ability and willingness to sign informed consent for participation in the study

Exclusion Criteria

* Unwillingness or inability to participate in the study
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Tirat Carmel Mental Health Center

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Anatoly Dr. Kreinin

Director of psychiatric department

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Anatoly Kreinin, MD, PHD

Role: PRINCIPAL_INVESTIGATOR

B. Rappaport Faculty of Medicine, Technion, Haifa

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Tirat Carmel Mental Health Center

Tirat HaCarmel, Tirat HaCarmel, Israel

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Israel

References

Explore related publications, articles, or registry entries linked to this study.

Kreinin A, Novitski D, Rabinowitz D, Weizman A, Grinshpoon A. Association between tobacco smoking and bipolar affective disorder: clinical, epidemiological, cross-sectional, retrospective study in outpatients. Compr Psychiatry. 2012 Apr;53(3):269-74. doi: 10.1016/j.comppsych.2011.04.063. Epub 2011 Jun 12.

Reference Type DERIVED
PMID: 21664608 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

GKN2007

Identifier Type: -

Identifier Source: secondary_id

GKN2007

Identifier Type: -

Identifier Source: org_study_id